contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


canatu-will-release-its-financial-statements-bulletin-for-the-2024-financial-year-on-friday-march-28-2025

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Rarely do tenbaggers stay long at the valuation levels that made them tenbaggers, and one characteristic of this is a very high P/S. For example, QT is now only a sixth of its 180€ share price. So, markets should not be underestimated. It’s quite possible that Canatus will also see a massive overshoot upwards someday.

I certainly wouldn’t value, for example, a medical device company at a P/S of ten or an automotive OEM. You can take as a comparison, for instance, Siemens Healthineers, whose P/S is around 2, or DENSO (in some collaboration with Canatu), whose P/S is 0.5. A stock shouldn’t really be valued based on P/S, but rather on future cash flow. If we assume for Canatu, for example, a 300M€ revenue and a 100M€ profit (which in itself would already be very strong), a market capitalization of 3 billion would require a growth rate of around 20% even after 10 years.

You are now focusing your assessment on the semiconductor sector. In ten years, other fields might also gain momentum. Some of them might even generate hype.

Seriously, that 10X would require a market capitalization of over 3.5 billion. If you look at Canatu’s own estimates of the market size, for example, it’s completely incomprehensible to expect such an increase in value, and in a relatively short time at that.

Canatu is indeed a good candidate to become a ten-bagger with a 10-year horizon, as there are other potential applications besides pellicles for the semiconductor industry, and the company’s playing field is global.

Does Inderes believe that Cantu’s share price will increase tenfold with a 12% or even greater probability? One might infer something like that from the size of the bet.

Look what ended up in the Model Portfolio.  We bought Canatu, a manufacturer of advanced carbon nanotubes, as a new company for the Model Portfolio. After its SPAC listing in September 2024, Canatu has had to postpone its ambitious growth targets, and the stock has been under pressure this year. In our opinion, the company’s long-term potential remains unchanged, and in the semiconductor sector, demand for the company’s EUV pellicle films made from carbon nanotubes is accelerating in the coming years. The company’s valuation (2025e-2026e EV/S 14x-7x) requires strong growth in the coming years, but we see a realistic path for the company to multiply its revenue over the next 5 years. Should this materialize, the stock would also, in our view, offer an excellent return from current levels. Due to a significantly higher-than-average risk level, we added the company to the Model Portfolio with a smaller 3.5% weighting. With this transaction, the Model Portfolio’s cash weighting decreased to just over 13%.                   Inderes              Mallisalkku: Otimme pienen rivin Canatua salkkuun - Inderes    Ostimme edistyneitä hiilinanoputkia valmistavaa Canatua uutena yhtiönä Mallisalkkuun.

Canatu

Canatu Plc Press release 20 March 2025 at 09:00 am EETCanatu will release its Financial Statements Bulletin for the 2024 financial year on Friday, March 28, 2025 Canatu's financial statement...

Canatu Plc Press release 20 March 2025 at 09:00 am EETCanatu will release its Financial Statements Bulletin for the 2024 financial year on Friday, March 28, 2025 Canatu's financial statement for the 2024 financial year (January 2024 – December 2024) will be published on March 28, 2025, at approximately 9:00 a.m.Canatu's CEO Juha Kokkonen and interim CFO Mikko Vesterinen will present the results in English to investors, analysts, and the media on the publication day from 13:00 to 14:00. You can register for and watch the webcast at <a href="https://canatu.videosync.fi/q4-2024">https://canatu.videosync.fi/q4-2024</a>. The event can also be attended in person at the Sanomatalo event studio Eliel (Töölönlahdenkatu 2, 00100 Helsinki).During the event, you will have the opportunity to ask questions using the chat function in Finnish and English.A recording of the event will be available later the same day on Canatu’s investor pages at <a href="https://canatu.com/investors/reports-and-presentations/">https://canatu.com/investors/reports-and-presentations/</a>Additional informationCEO Juha Kokkonen, tel. +358 405 430&nbsp;367Board member Tuomo Vähäpassi, <a href="mailto:tuomo.vahapassi@lifeline-spac1.com">tuomo.vahapassi@lifeline-spac1.com</a>Certified Adviser Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65About Canatu&nbsp; Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Together with pioneering companies, Canatu transforms products with nano carbon for a better tomorrow.&nbsp;&nbsp;Canatu's versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.&nbsp;&nbsp;Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan.&nbsp;Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 140 employees representing over 35 nationalities, with 20 per cent holding or pursuing doctorates. Discover more at <a href="http://www.canatu.com">www.canatu.com</a> and follow us on <a href="https://www.linkedin.com/company/canatu/">LinkedIn</a>.&nbsp;